Breast cancer patients were selected who underwent core needle biopsy sampling, followed by CET neoadjuvant chemotherapy regimens, and finally surgical removal of the breast tumors. Each patient derived 3-4 core needle biopsy specimens prior to NAC, and each post-NAC tumor tissue was spatially dissected into 6-7 sectors; (B) Breast cancer patients were selected whose breast tumors were surgically removed without neoadjuvant chemotherapy treatment. Each tumor tissue was spatially dissected into 6 sectors. assay that amplifies a DNA strand without any cytosine to determine the total DNA amounts in each sample. Genomic coordinate is referred to UCSC hg19; (B) The C-LESS-C1 assay is measured by the HEX-labelled probe, meanwhile 2 genes of interest are measured by the 2 gene-specific FAM-labelled probes adjusted at different concentrations. The accuracy of ddPCR is sufficient to display the 2 genespecific FAM-positive droplets at 2 distinctively separated FAM altitudes, enabling quantification of the 2 genes with 1 fluorescent channel. For the first assay, Gene A = ALDH1L1, Gene B = SOX9; for the second assay, Gene A = HOPX, Gene B = WNT5A. Thus, the 4 genes can be measured with only 2 assays. 
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